AP NEWS

Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2018 - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

This research provides insights into Anxiety Disorder epidemiology, Anxiety Disorder diagnosed patients, and Anxiety Disorder treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Anxiety Disorder derived from epidemiological analysis, patients diagnosed with Anxiety Disorder, and patients treated with a drug therapy.

The research study helps executives estimate Anxiety Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Anxiety Disorder prevalence, Anxiety Disorder diagnosis rate, and Anxiety Disorder treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

Anxiety Disorder Patient Flow Anxiety Disorder Prevalence Anxiety Disorder Diagnosed Patients Anxiety Disorder Treated Patients

Key Topics Covered

1. Anxiety Disorder: Disease Definition

2. Global Anxiety Disorder Patient Flow

2A. Global Anxiety Disorder Prevalence

2B. Global Anxiety Disorder Diagnosed Patients

2C. Global Anxiety Disorder Treated Patients

3. Anxiety Disorder Patient Flow in the US

3A. Anxiety Disorder Prevalence in the US

3B. Anxiety Disorder Diagnosed Patients in the US

3C. Anxiety Disorder Treated Patients in the US

4. Anxiety Disorder Patient Flow in Europe

4A. Anxiety Disorder Prevalence in Europe

4B. Anxiety Disorder Diagnosed Patients in Europe

4C. Anxiety Disorder Treated Patients in Europe

5. Anxiety Disorder Patient Flow in Germany

5A. Anxiety Disorder Prevalence in Germany

5B. Anxiety Disorder Diagnosed Patients in Germany

5C. Anxiety Disorder Treated Patients in Germany

6. Anxiety Disorder Patient Flow in France

6A. Anxiety Disorder Prevalence in France

6B. Anxiety Disorder Diagnosed Patients in France

6C. Anxiety Disorder Treated Patients in France

7. Anxiety Disorder Patient Flow in Spain

7A. Anxiety Disorder Prevalence in Spain

7B. Anxiety Disorder Diagnosed Patients in Spain

7C. Anxiety Disorder Treated Patients in Spain

8. Anxiety Disorder Patient Flow in Italy

8A. Anxiety Disorder Prevalence in Italy

8B. Anxiety Disorder Diagnosed Patients in Italy

8C. Anxiety Disorder Treated Patients in Italy

9. Anxiety Disorder Patient Flow in UK

9A. Anxiety Disorder Prevalence in UK

9B. Anxiety Disorder Diagnosed Patients in UK

9C. Anxiety Disorder Treated Patients in UK

10. Anxiety Disorder Patient Flow in Japan

10A. Anxiety Disorder Prevalence in Japan

10B. Anxiety Disorder Diagnosed Patients in Japan

10C. Anxiety Disorder Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/3sqnmt/global_anxiety?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612006431/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Anxiety Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 03:48 PM/DISC: 06/12/2018 03:48 PM

http://www.businesswire.com/news/home/20180612006431/en

AP RADIO
Update hourly